Visceral Leishmaniasis Relapse in HIV Patients—A Role for Myeloid-Derived Suppressor Cells?

• Rafael Van den Bergh,

  Affiliations Laboratory for Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium, Myeloid Cell Immunology Laboratory, VIB, Brussels, Belgium, Operational Research Unit, Medical Department, Médecins Sans Frontières – Operational Centre Brussels, Brussels, Belgium

  ⨯
• Jo A. Van Ginderachter,

  Affiliations Laboratory for Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium, Myeloid Cell Immunology Laboratory, VIB, Brussels, Belgium

  ⨯
• Elio Schouppe,

  Affiliations Laboratory for Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium, Myeloid Cell Immunology Laboratory, VIB, Brussels, Belgium

  ⨯
• Belete A. Desimmie,

  Affiliation Department of Pharmaceutical and Pharmacological Sciences, Katholieke Universiteit Leuven, Leuven, Belgium

  ⨯
• Asrat Hailu,

  Affiliation Faculty of Medicine, Addis Ababa University, Addis Ababa, Ethiopia

  ⨯
• Patrick De Baetselier,

  Affiliations Laboratory for Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium, Myeloid Cell Immunology Laboratory, VIB, Brussels, Belgium

  ⨯
• Johan van Griensven

  * E-mail: jvangriensven@itg.be

  Affiliation Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium

  ⨯